The Effect of İnhaler Training and Reminders on Medication on Adherence in Elderly Individuals
Elderly (People Aged 65 or More)
What this study involves
The registry says this study is recruiting. Individual locations may have different availability.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 65 years - Not specified
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 64 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
This study will evaluate the effect of metered-dose inhaler training and reminders on treatment adherence in elderly individuals.
Read the full description
The presence of multiple comorbidities and an increased number of medications in elderly individuals are significant risk factors for non-adherence to inhaler therapy. Forgetfulness, lack of confidence in medications and difficulty understanding how to take them, depression, low self-efficacy, disease severity, and disease perception can all affect adherence to treatment. Incorrect inhaler use can lead to patients receiving insufficient medication, increased symptom burden, and negatively impact their quality of life. Furthermore, incorrect inhaler technique has been shown to increase the risk of hospitalization, emergency room visits, and the use of antibiotics and oral corticosteroids. Implementing procedures to ensure correct inhaler use is crucial in controlling critical errors in inhaler therapy. Elderly patients are more likely to have conditions such as arthritis that affect physical movement and coordination. Cognitive function also affects the ability to use inhaler devices correctly. It is known that incorrect inhaler use is more common, particularly in untrained and elderly individuals, with frequent errors including poor hand-mouth coordination, inability to synchronize spraying and inhalation, and failure to hold the breath during inhalation being common mistakes in metered-dose inhaler use. Therefore, this study will evaluate the effect of metered-dose inhaler training and reminders on treatment adherence in elderly individuals.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion criteria for the study:
- Age ≥ 65 years old
- Having at least basic literacy,
- Receiving metered-dose inhaler therapy for at least 6 months,
- Being hospitalized in the pulmonary ward,
- Presenting to the pulmonary function test unit,
- Presenting to the pulmonary outpatient clinic,
- Signing the informed consent form for participation in the study,
- Having internet access and a mobile device with Android/iOS operating system,
- Being able to use a telephone,
- Having no communication barriers,
- Being able to use the inhaler without needing assistance,
- Making an error in at least one of the usage steps according to the MDI usage skills chart.
Exclusion criteria for the study:
- Age \<65
- Illiteracy
- Receiving metered-dose inhaler therapy for \<6 months
- Outpatient treatment
- Being hospitalized in the intensive care unit
- Being hospitalized in wards other than the pulmonary ward (such as surgery, physical therapy)
- Visiting outpatient clinics other than the pulmonary clinic (such as surgery, physical therapy)
- Not signing the informed consent form for participation in the study
- Not having internet access and a mobile device with Android/iOS operating system
- Not having telephone skills
- Having communication barriers
- Requiring assistance while using the inhaler
- Not making any errors in the usage steps according to the MDI usage skills chart
- Wanting to withdraw from the study/withdrawing from participation during the research process
- Not completing the questionnaire
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- No masking
arm description experimental
The socio-demographic and descriptive characteristics, as well as questions regarding medication adherence, included in the survey form will be answered through face-to-face interviews. While the participant demonstrates how to apply the inhaler, the researcher will evaluate the participant's inhaler use according to the "Metered Dose Inhaler Skill Chart," which includes the steps for inhaler use. Each participant in the experimental group will receive metered-dose inhaler training using a demonstration method. At the end of the training, participants will be given a "Metered Dose Inhaler Use Reminder Card" and a "Metered Dose Inhaler Application Video." Participants will also receive weekly reminders via telephone. After 3 months, the experimental group will be contacted via video call to demonstrate how they use the inhaler. The researcher will evaluate the participants' medication adherence scores and record them on the survey form. If any steps are incorrectly applied, the metered
Other: Metered Dose Inhaler Training · Other: Metered Dose Inhaler Reminder Card · Other: Metered Dose Inhaler Application Video
arm description control
The socio-demographic and demographic characteristics, as well as questions regarding medication adherence, included in the survey form will be answered through face-to-face interviews. While the participant demonstrates how to apply the inhaler, the researcher will evaluate the participant's inhaler use according to the "Metered Dose Inhaler Skill Chart," which includes the steps for inhaler use. No inhaler training or reminders will be given. Participants in the control group will be contacted by phone 3 months after the initial follow-up and asked to demonstrate how they use the inhaler. The researcher will evaluate the participants' medication adherence scores and record them on the survey form. After the data collection is complete, inhaler training will be given to the participants using a demonstration method. At the end of the training, reminder cards and a video demonstrating metered-dose inhaler application will be shared with the participants.
Metered Dose Inhaler Training OTHER
It is known that incorrect inhaler use is more common, especially in elderly individuals, and that common errors in metered-dose inhaler use include poor hand-mouth coordination, inability to simultaneously spray and inhale, and failure to hold the breath during inhalation. This study evaluates metered-dose inhaler use only in elderly individuals. Furthermore, not only will the inhaler application steps be evaluated, but the experimental group will also receive education and reminder interventions.
Metered Dose Inhaler Reminder Card OTHER
This reminder card contains the inhaler administration steps included in the "Measured Dose Inhaler Medication Use Skill Chart". Participants in the experimental group will be able to access the medication administration steps on the reminder card before administering their inhaler medication. Participants will be asked in the final interview whether they used the reminder cards.
Metered Dose Inhaler Application Video OTHER
This video was prepared by the responsible researcher, taking into account the application steps included in the "Metered Dose Inhaler Medication Use Skill Chart". Participants in the experimental group will be able to access the application steps via the inhaler video before administering their inhaler medication.
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Metered Dose Inhaler Skill
Time frame: the initial screening and three months after the initial screening (three months)
The "Measured Dose Inhaler Skill Chart" involves evaluating the participant's inhaler usage and checking the application steps. Performing all steps correctly will be considered "correct inhaler technique," while performing at least one or more steps incorrectly or not at all will be considered "incorrect inhaler technique." For each step, incorrect application or omission will receive "0 points," and correct application will receive "1 point," resulting in a total score between "0 and 10." Participants who make at least "1 mistake" or score "below 10" will be included in the study. When evaluating scores based on inhaler usage steps, "0-3" points will be considered poor, "4-6" points moderate, and "7-10" points good.
Medication Adherence Reporting Scale
Time frame: the initial screening and three months after the initial screening (three months)
The scale consists of 5 items in total. The total test score is determined by summing the scores obtained from the items. Scores obtained from the scale range from 5 to 25. Higher total scores indicate better medication adherence, while lower total scores indicate poor medication adherence.
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (1)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
1 locations
Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart UniversityÇanakkale, Turkey (Türkiye)Recruiting
Study team and timeline
- Lead sponsor
- Çanakkale Onsekiz Mart University
- Study start
- Jan 21, 2026 Actual
- Primary completion
- Dec 23, 2026 Estimated
- Study completion
- Dec 30, 2026 Estimated
- First posted
- Feb 2, 2026 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
The Effect Of Metered-Dose İnhaler Training And Reminders On Medication Adherence In Elderly Individuals: A Randomized Controlled Study
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026
